Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 246

1.

Direct improvement of quality of life in colorectal cancer patients using a tailored pathway with quality of life diagnosis and therapy (DIQOL): study protocol for a randomised controlled trial.

Klinkhammer-Schalke M, Lindberg P, Koller M, Wyatt JC, Hofstädter F, Lorenz W, Steinger B.

Trials. 2015 Oct 14;16:460. doi: 10.1186/s13063-015-0972-y.

2.

Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.

Breyer J, Gierth M, Shalekenov S, Aziz A, Schäfer J, Burger M, Denzinger S, Hofstädter F, Giedl C, Otto W.

World J Urol. 2016 May;34(5):709-16. doi: 10.1007/s00345-015-1690-5. Epub 2015 Sep 22.

PMID:
26394624
3.

4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival.

Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Gerstenhauer M, Brockhoff G, Ortmann O.

Breast Cancer Res Treat. 2015 Oct;153(3):647-58. doi: 10.1007/s10549-015-3572-3. Epub 2015 Sep 14.

4.

Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.

Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Lindberg P, Gerstenhauer M, Schüler S, Treeck O, Ortmann O.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2229-40. doi: 10.1007/s00432-015-2025-z. Epub 2015 Aug 8.

5.

Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study.

Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Wieland W, Eder F, Hofstädter F, Schilling D, Sievert KD, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Kurt Werner S, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Gratzke C, Stief C, Wiegel T, Haese A.

Radiother Oncol. 2015 Jul;116(1):119-24. doi: 10.1016/j.radonc.2015.06.021. Epub 2015 Jun 29.

PMID:
26138059
6.

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer.

Teufel A, Gerken M, Hartl J, Itzel T, Fichtner-Feigl S, Stroszczynski C, Schlitt HJ, Hofstädter F, Klinkhammer-Schalke M.

BMC Cancer. 2015 May 20;15:419. doi: 10.1186/s12885-015-1404-9.

7.

White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study.

Leifeld L, Rogler G, Stallmach A, Schmidt C, Zuber-Jerger I, Hartmann F, Plauth M, Drabik A, Hofstädter F, Dienes HP, Kruis W; Detect Dysplasia Study Group.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1776-1781.e1. doi: 10.1016/j.cgh.2015.04.172. Epub 2015 May 5.

PMID:
25952309
8.

Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.

Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, Salvadori U, Bründl J, Fritsche HM, Hofstädter F, Pawlik MT, Otto W, May M, Burger M, Denzinger S.

J Cancer Res Clin Oncol. 2015 Oct;141(10):1819-26. doi: 10.1007/s00432-015-1957-7. Epub 2015 Apr 2.

PMID:
25832016
9.

The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Burger M, Eder F, Hofstädter F, Schilling D, Sievert K, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Schmid K, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Stief C, Haese A.

World J Urol. 2015 Jul;33(7):973-9. doi: 10.1007/s00345-015-1510-y. Epub 2015 Feb 15.

PMID:
25682109
10.

Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer.

Bertz S, Abeé C, Schwarz-Furlan S, Alfer J, Hofstädter F, Stoehr R, Hartmann A, Gaumann AK.

Virchows Arch. 2014 Dec;465(6):687-95. doi: 10.1007/s00428-014-1672-9. Epub 2014 Oct 19.

PMID:
25326864
11.

Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.

Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A.

Urol Int. 2014;93(3):311-9. doi: 10.1159/000360483. Epub 2014 Sep 4.

PMID:
25196313
12.

Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry.

Inwald EC, Ortmann O, Zeman F, Koller M, Hofstädter F, Gerstenhauer M, Klinkhammer-Schalke M.

Biomed Res Int. 2014;2014:137304. doi: 10.1155/2014/137304. Epub 2014 Mar 20.

13.

[Clinical and epidemiological cancer registries: two complementary sources of information on cancer incidence].

Hofstädter F, Hentschel S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):27-32. doi: 10.1007/s00103-013-1871-6. German.

PMID:
24357169
14.

Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.

Rogler A, Hoja S, Socher E, Nolte E, Wach S, Wieland W, Hofstädter F, Goebell PJ, Wullich B, Hartmann A, Stoehr R.

Int J Clin Exp Pathol. 2013 Sep 15;6(10):1984-98. eCollection 2013.

15.

Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.

Rubenwolf PC, Otto W, Denzinger S, Hofstädter F, Wieland W, Georgopoulos NT.

World J Urol. 2014 Aug;32(4):991-7.

PMID:
24022233
16.

Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients.

Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F.

Clin Genitourin Cancer. 2013 Dec;11(4):537-44. doi: 10.1016/j.clgc.2013.05.001. Epub 2013 Jul 10.

PMID:
23850551
17.

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.

Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O.

Breast Cancer Res Treat. 2013 Jun;139(2):539-52. doi: 10.1007/s10549-013-2560-8. Epub 2013 May 16.

18.

Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.

May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S.

BJU Int. 2013 Aug;112(4):E383-90. doi: 10.1111/j.1464-410X.2012.11735.x. Epub 2013 Jan 10.

19.

Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders' grading of penile squamous cell carcinomas.

Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M.

Urol Int. 2013;90(2):207-13. doi: 10.1159/000342639. Epub 2012 Oct 26.

PMID:
23108244
20.

Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.

Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M.

Eur Urol. 2013 Apr;63(4):739-44. doi: 10.1016/j.eururo.2012.09.053. Epub 2012 Sep 28.

PMID:
23079053
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk